Article

The Role of the Biomanufacturing Industry in Developing Diagnostics and mRNA Vaccines Against COVID-19

2026-05-07

Abstract excerpt

COVID-19, caused by a novel virus, SARS-CoV-2, has now become international endemic. It posed a challenge to the global biomanufacturing industry for rapid diagnostics, effective therapeutics, and scalable vaccine manufacturing. The biomanufacturing industry played a central role in meeting this challenge by accelerating the development, production, and distribution of SARS‑CoV‑2 diagnostic assays and vaccines. Th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 492c5992-ff62-5400-81e2-888fe2366587
DOI: 10.20944/preprints202601.1387.v3

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The Role of the Biomanufacturing Industry in Developing Diagnostics and mRNA Vaccines Against COVID-19DOI 10.20944/preprints202601.1387.v3Read

The Role of the Biomanufacturing Industry in Developing Diagnostics and mRNA Vaccines Against COVID-19Semantic proximity Read

From COVID-19 to Global Health: Challenges and Opportunities in mRNA Vaccine ProductionSemantic proximity Read

mRNA Vaccines: Design Principles, Mechanisms, and Manufacturing—Insights From COVID‐19 as a Model for Combating Infectious DiseasesSemantic proximity Read

Enabling mRNA Therapeutics: Current Landscape and Challenges in ManufacturingSemantic proximity Read

mRNA Vaccines Five Years After COVID-19: Lessons in Platform Design, Real-World Effectiveness, and EquitySemantic proximity Read

Advancing mRNA vaccines for infectious diseases: key components, innovations, and clinical progressSemantic proximity Read

Accelerating manufacturing to enable large-scale supply of a new adenovirus-vectored vaccine within 100 daysSemantic proximity Read

Platforms, advances, and technical challenges in virus-like particles-based vaccinesSemantic proximity Read

mRNA Vaccine Platforms and Lipid Nanoparticle Delivery Systems: Molecular Advances, Clinical Breakthroughs, and Regulatory Perspectives (2020–2025)Semantic proximity Read

Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic DemandSemantic proximity Read

Reshaping Cell Line Development and CMC Strategy for Fast Responses to Pandemic OutbreakSemantic proximity Read

A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stabilitySemantic proximity Read